Mercer Global Advisors
LEGN icon

Mercer Global Advisors’s Legend Biotech LEGN Stock Holding History

Mercer Global Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Buy
+856
New +$23.1K ﹤0.01% 4715

Other funds holding LEGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $587M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Mercer Global Advisors's LEGN Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Legend Biotech (LEGN) in Q2 2026: 856 shares worth $24.7K. The stake represents ﹤0.01% of the portfolio and ranks #4715 among its holdings.

178 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Mercer Global Advisors held 856 shares of Legend Biotech worth $24.7K as of Q2 2026.
  • Legend Biotech was a new Mercer Global Advisors position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4715 holding.
  • 178 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.